Eli Lilly (Germany) Today

LLY Stock  EUR 720.70  10.70  1.51%   

Performance

0 of 100

 
Weak
 
Strong
Very Weak

Odds Of Distress

Less than 9

 
High
 
Low
Low
Eli Lilly is selling at 720.70 as of the 25th of November 2024; that is 1.51% up since the beginning of the trading day. The stock's lowest day price was 717.4. Eli Lilly has less than a 9 % chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Eli Lilly and are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 29th of February 2024 and ending today, the 25th of November 2024. Click here to learn more.

Moving against Eli Stock

  0.82ADH2 Air CanadaPairCorr
  0.77AMZ Amazon IncPairCorr
  0.47MSF MicrosoftPairCorr
  0.46MSF MicrosoftPairCorr
  0.45MSF MicrosoftPairCorr
  0.44MSF MicrosoftPairCorr
Follow Valuation Odds of Bankruptcy
Check how we calculate scores

Eli Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Eli Lilly's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Eli Lilly or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Business ConcentrationOther, Other (View all Sectors)
Eli Lilly and (LLY) is traded on Hamburg Exchange in Germany . The company operates under Other sector and is part of Other industry. Eli Lilly generates positive cash flow from operations, but has no cash available
Check Eli Lilly Probability Of Bankruptcy

Eli Lilly Risk Profiles

Although Eli Lilly's alpha and beta are two of the key measurements used to evaluate Eli Lilly's performance over the market, the standard measures of volatility play an important role as well.

Eli Stock Against Markets

Be your own money manager

Our tools can tell you how much better you can do entering a position in Eli Lilly without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Portfolio Analyzer Now

   

Portfolio Analyzer

Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
All  Next Launch Module

Additional Information and Resources on Investing in Eli Stock

When determining whether Eli Lilly offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Eli Lilly's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Eli Lilly And Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Eli Lilly And Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Eli Lilly and. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Please note, there is a significant difference between Eli Lilly's value and its price as these two are different measures arrived at by different means. Investors typically determine if Eli Lilly is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Eli Lilly's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.